CAPR Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CAPR shares is 115, representing 18.82% of the company's common stock.

BANK OF AMERICA CORP /DE/, in the last quarter, reduced its stake in CAPR by -7.27% restricting it's holding to 22 thousand shares of worth nearly $149.39K. WOODLINE PARTNERS LP also lessened -98.63% of the CAPR shares from its portfolio, reducing its holding to 12.46 thousand shares of worth $84.61K. DIMENSIONAL FUND ADVISORS LP also shunned CAPR shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, MILLENNIUM MANAGEMENT LLC increased its stake in CAPR by 1,292.91% in the last quarter. The institutional holder raised its holding to 293.04 thousand shares having worth more than $1.99M. TWO SIGMA INVESTMENTS, LP also added 21.83% more shares of CAPR to its portfolio, raising its holding to 24 thousand shares of worth $162.96K. HIGHTOWER ADVISORS, LLC also increased its CAPR shares holding by 100% which brought its holding to 24 thousand shares worth $7.20K.

The insider with the most stakes in CAPR is Nippon Shinyaku Co Ltd , 10 percent owner at the company. Additionally, CAPR stock is highly held by 10 percent owner CEDARS SINAI MEDICAL CENTER and director TANEN DAVID M among others.

Company executives, directors, and other insiders own 16.75% percent of Capricor Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which CAPR insiders have sold stock, totaling 0 shares. Insiders that have sold shares include AVAT XAVIER and MUSKET DAVID B.

There have been 1 transaction(s) during the past 6-months in which Capricor Therapeutics, Inc. insiders have bought stock, totalling 2798507 shares

Around 7.09M Capricor Therapeutics, Inc. shares are held by insiders, which represents about 16.75% of CAPR stock.

CAPR 10 percent owner, Nippon Shinyaku Co Ltd holds the largest portfolio of the company's shares. CAPR shares owned by Nippon total nearly 7.09 million.

MILLENNIUM MANAGEMENT LLC is the largest institutional owner in CAPR which holds 293.04 thousand shares worth $1.99M or 0.96% of the total CAPR shares outstanding followed by TWO SIGMA INVESTMENTS, LP with ownership of 24 thousand shares representing 0.08% of the CAPR ownership. HIGHTOWER ADVISORS, LLC is the third largest stakeholder with 24 thousand shares or 0.08% of the ownership worth more than $7.20K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CAPR is concerned, it is a stock which is optionable.

Number of CAPR shares short is 7.95M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 45.47M shares of CAPR are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CAPR has 25.70M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CAPR is 4.83.